US

CONFIDENCE IN ENDURING SCS THERAPY

Only the Evoke® System provides an objective and physiologic measure of the spinal cord’s response to stimulation and can automatically adjust on every pulse to provide precise and consistent neural activation

Evoke SmartLoop logo

The first and only FDA-approved smart spinal cord stimulation system (SCS) that can directly measure the spinal cord’s response to stimulation in real time through Evoked Compound Action Potentials (ECAPs) and automatically adjust in real time, up to 4+Million times a day*.

CE/TGA Indications for Use: The Evoke® System is indicated as an aid in the management of chronic intractable pain of the trunk and/or limbs.

The Evoke® System Powered By SmartLoop™ Technology Redefines Spinal Cord Stimulation

Spinal Cord Stimulation gif

Only SmartLoopTM Technology can automatically adjust stimulation 4+ million times a day
to deliver precise and consistent neural activation.*

Only SmartLoop™ Technology Enables Clinicians To Directly Measure And Prescribe A Precise Dose Of Stimulation Based On ECAPs Unique To Every Patient

Saluda Medical pioneered the ability to directly measure Evoked Compound Action Potentials (ECAPs) in the spinal cord after more than a decade of advanced research and development.

  • ECAPs are an objective measure of neural activation and the spinal cord’s response to stimulation
  • Neural activation drives pain inhibition
  • Consistent and precise neural activation delivers more consistent pain relief

Pain Relief with Spinal Cord Stimulation Starts with
Neural Activation

An Evoked Compound Action Potential (ECAP) is a direct, physiologic measure of aß-fiber activation within the dorsal column
of the spinal cord

Spinal cord stimulation diagram

Reduce clinical burden and improve practice efficiency

The EVOKE Study demonstrated a reduction in follow-up office visits due to device reprogramming needs

0

explants due to loss of efficacy at 36 months1

<1

Reprogramming visits per patient per year1 (beyond 12 months)

Gain confidence and peace of mind

Deliver consistent neural activation for consistent pain relief

Elipse 94%

94%

EVOKE study patients with SmartLoop™ Technology received therapeutic stimulation 94% of the time compared to open-loop patients receiving therapeutic stimulation 46% of the time.1

Achieve high patient satisfaction

Demonstrated superior outcomes can increase patient awareness

Elipse 93%

93%

of patients were satisfied with therapy1

Contact An Evoke® System Professional Today

Additional Resources

Evoke SCS System Physician Brochure

Evoke SCS System Therapy + Access to MRI

Evoke SCS System MRI Scanning Checklist

Getting an MRI Scan Patient Guide